Industry Focus

Biotech's biggest stories this year include trial data and FDA decisions for therapies targeting indications with a massive need for new treatment options, including blood disorders, genetic diseases, and Alzheimer's Disease. Here are six stocks that could pop or drop in 2019 based on these fast-approaching catalysts. Stocks: BIIB, BLUE, GBT, AIMT, DBVT, VRTX, SRPT

Check out more of our content here:

Direct download: 201901_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST